Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

JP 2025531200-A2025-09-19

GIP AND GLP-1 DUAL AGONIST COMPOUNDS

Eli Lilly and Company

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020250140094-A2025-09-24

GIP/GLP1/GCG TRI-RECEPTOR AGONISTS AND USES THEREOF

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020250140094-A2025-09-24
- JP 2026505071-A2026-02-10
EP 4622997-A22025-10-01

MELANOCORTIN AND GLP-1 RECEPTOR AGONISTS AND METHODS OF USE

SEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020250155052-A2025-10-29

COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME

PERSEPHONE BIOSCIENCES, INC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2025234425-A2025-11-13

Patent application sequence for WO 2025234425-A/10

Glytech, Inc

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
EP 4658683-A12025-12-10

COMPOSITIONS AND METHODS FOR ANTI-PACAP IGG4 ANTIBODIES

CEPHALON LLC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 4658683-A12025-12-10
- JP 2026504452-A2026-02-05
US 12528852-B22026-01-20

Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs

Jie Han

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2026024920-A12026-01-29

Fc-ACYLATED POLYPEPTIDE CONJUGATES

ELI LILLY AND COMPANY

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2026024920-A12026-01-29
- JP 2026031900-A2026-02-25
US 12551541-B22026-02-17

Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor

AlbuNext, LLC

Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US202363523324P.
- US 12551541-B22026-02-17
- EP 4731246-A22026-04-29
- EP 4731264-A12026-04-29
JP 2026507189-A2026-02-27

COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND OF USING SAME

PERSEPHONE BIOSCIENCES, INC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2026048634-A2026-03-17

IGG FC VARIANTS FOR VETERINARY USE

ELANCO US INC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||||||||| |
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGAG 31
```
30 of 31 identical, no gaps.
EP 4709164-A12026-03-18

PHARMACEUTICAL COMPOSITIONS AND THEIR USES, AND METHODS FOR IMPROVING THE STORAGE STABILITY OF PHARMACEUTICAL COMPOSITIONS

SHANGHAI BENEMAE PHARMACEUTICAL CORP

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 4709164-A12026-03-18
- JP 2026517891-A2026-06-02
EP 4709406-A22026-03-18

ANXIOLYTIC THERAPY

UNIV HOSPITALS CLEVELAND MEDICAL CENTER

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
EP 4805385-A12026-09-16

MODULATION OF THIRST

UNIV HOSPITALS CLEVELAND MEDICAL CENTER

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 03057235-A22003-07-17

Modification of feeding behavior

Imperial College Innovations Limited (GB)

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||| ||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGGAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
EP 1419783-A22004-05-19

Use of a composition comprising an exendin or a compound derived therefrom and a pharmaceutical carrier

AMYLIN PHARMACEUTICALS, INC. (US)

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||| |||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 7344856-A2008-03-18

Method of controlling cleavage by OmpT protease

Asubio Pharma Co. Ltd.

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 154 to 184. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          ||||||||||||||||||||||||||| |||
Hit   154 HAEGTFTSDVSSYLEGQAAKEFIAWLVLGRG 184
```
30 of 31 identical, no gaps.
JP 2009292835-A2009-12-17

Modification of Feeding Behavior

Imperial College Innovations LTD,Oregon Health and Science University

Query Match 95.7%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||| ||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGGAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2009292835-A2009-12-17
- JP 2011052018-A2011-03-17
EP 2329839-A12011-06-08

Modification of feeding behavior by GLP-1 and PYY

IMP INNOVATIONS LTD

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||| ||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGGAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 8058233-B22011-11-15

Modification of feeding behavior using PYY and GLP-1

Oregon Health and Science University and Imperial Innovations Limited

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||| ||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGGAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
EP 2479193-A12012-07-25

HOMODIMER OF INSULINOTROPIC PEPTIDE ANALOGUES AND METHOD FOR PREPARATION THEREOF AND USE THEREOF

CHONGQING FAGEN BIOMEDICAL INC

Query Match 95.7%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||||||||| |
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 31
```
30 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2479193-A12012-07-25
- US 8557771-B22013-10-15
WO 2013083826-A22013-06-13

GLP-1 AGONISTS

NOVO NORDISK AS

Query Match 95.7%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
WO 2014191545-A12014-12-04

NOVEL ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES

NOVO NORDISK AS

Query Match 95.7%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2014191545-A12014-12-04
- JP 2016524617-A2016-08-18
JP 2015500823-A2015-01-08

GLP-1 AGONISTS

NOVO NORDISK A/S

Query Match 95.7%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
JP 2015214553-A2015-12-03

GLUCAGON-LIKE PEPTIDE-1 ANALOGUES AND USES THEREOF

Betta Pharmaceuticals Co Ltd

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
JP 2016538831-A2016-12-15

Acylated glucagon analogues

Zealand Pharma A/S,Boehringer Ingelheim International GmbH

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
EP 3398960-A12018-11-07

METHOD FOR PREPARING SERMAGLUTIDE

HYBIO PHARMACEUTICAL CO LTD

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
WO 2020169658-A22020-08-27

AMINOACYL-TRNA SYNTHETASES AND USES HEREOF

NOVO NORDISK AS

Query Match 95.7%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020169658-A22020-08-27
- JP 2022521321-A2022-04-06
WO 2020190757-A12020-09-24

IMPROVED PROCESSES FOR THE PREPARATION OF SEMAGLUTIDE

NOVETIDE LTD

Query Match 95.7%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
US 11203614-B22021-12-21

Composite polypeptide having a metal binding motif and molecular construct comprising the same

IMMUNWORK INC.

Query Match 95.7%Identity 93.5%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- US 11203614-B22021-12-21
- JP 2022528318-A2022-06-10
- JP 2024023357-A2024-02-21
- US 11926678-B22024-03-12
JP 2022516027-A2022-02-24

IGG FC VARIANTS FOR VETERINARY USE

KINDRED BIOSCIENCES INC,Hangjun ZHAN et al

Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 295 to 325. Positions start at 1 and include both ends.
```
Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
          ||||||||||||||||||||||||||||| |
Hit   295 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 325
```
30 of 31 identical, no gaps.
KR 1020220157910-A2022-11-29

Composition For Combi-Therapy Comprising Growth Differentiation Factor-15 Variant and Glucagon-Like Peptide-1 Receptor Agonist

YUHAN CORPORATION

Query Match 95.7%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
JP 2023504184-A2023-02-01

PEPTIDE CONJUGATES AND METHODS OF USE

THE SCRIPPS RESEARCH INSTITUTE

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
KR 1020230039783-A2023-03-21

Pharmaceutical composition containing macromolecule and excipients

D&D Pharmatech Inc

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
KR 1020230102453-A2023-07-07

A conjugate of poly GLP1 variant

PROABTECH INC.

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 32 to 62. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit   32 HGEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 62
```
29 of 31 identical, no gaps.
JP 2023529486-A2023-07-10

SEMAGLUTIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

NINGBO KUNPENG BIOTECH CO LTD

Query Match 95.7%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
EP 4217503-A12023-08-02

A PROCESS FOR THE PREPARATION OF SEMAGLUTIDE AND SEMAPEPTIDE

DR REDDYS LABORATORIES LTD

Query Match 95.7%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
KR 1020230137987-A2023-10-05

LONG-ACTING AMYLIN RECEPTOR AGONISTS AND USES THEREOF

Eli Lilly and Company

Query Match 95.7%Identity 93.5%Family of 5
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230137987-A2023-10-05
- JP 2024508312-A2024-02-26
- US 12115210-B22024-10-15
- JP 2025090588-A2025-06-17
- US 12551532-B22026-02-17
JP 2024519950-A2024-05-21

COMPOSITION FOR COMBINATION THERAPY COMPRISING GROWTH DIFFERENTIATION FACTOR-15 VARIANT AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST

YUHAN CORPORATION

Query Match 95.7%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
EP 4380962-A12024-06-12

PROCESS FOR THE PREPARATION OF SEMAGLUTIDE

MSN LABORATORIES PRIVATE LTD R&D CENTER

Query Match 95.7%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
EP 4400094-A12024-07-17

PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT

D&D PHARMATECH INC

Query Match 95.7%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 4400094-A12024-07-17
- JP 2024533274-A2024-09-12
KR 1020240172375-A2024-12-10

A dual functional fusion protein with enhanced half-life and stability and a pharmaceutical composition for treating obesity comprising the same

UbiProtein. Corp

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 2 to 32. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||| |||||||||||
Hit    2 HGEGTFTSDVSSYLEGQAAREFIAWLVKGRG 32
```
29 of 31 identical, no gaps.
WO 2025026914-A12025-02-06

A METAL COMPLEX OF FMOC PROTECTED LIPOPEG-PEPTIDE WITH METAL HALIDE SALTS AND THE PREPARATION THEREOF

FRESENIUS KABI IPSUM S R L

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
WO 2025027052-A12025-02-06

ANTIBODY CONJUGATES AND FUSION PROTEINS

SIXPEAKS BIO AG

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
WO 2025078040-A12025-04-17

LYSINE SALT AND METHOD OF MANUFACTURING A LYSINE DERIVATIVE

BACHEM HOLDING AG

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
JP 2025088780-A2025-06-11

TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS

NOVO NORDISK A/S

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
KR 1020250084929-A2025-06-11

METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE

BACHEM HOLDING AG

Query Match 95.7%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020250084929-A2025-06-11
- JP 2025533940-A2025-10-09
WO 2025193896-A22025-09-18

LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY

LILLY CO ELI

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
JP 2025148269-A2025-10-07

LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY

Eli Lilly and Company

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
EP 4643872-A22025-11-05

LONG-ACTING AMYLIN RECEPTOR AGONISTS AND USES THEREOF

LILLY CO ELI

Query Match 95.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||||||||||||||| |||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 31
```
29 of 31 identical, no gaps.

GLP-1, a diabetes hormone

The search

Patents

Family of 2

Family of 2

Family of 2

Family of 3

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 4

Family of 5

Family of 2

Family of 2